Format

Send to

Choose Destination
Emerg Infect Dis. 2018 Oct;24(10):1816-1824. doi: 10.3201/eid2410.180649.

Candida auris in Healthcare Facilities, New York, USA, 2013-2017.

Abstract

Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilities in New York City, New York, USA. The investigation included laboratory surveillance, record reviews, site visits, contact tracing with cultures, and environmental sampling. We identified 51 clinical case-patients and 61 screening case-patients. Epidemiologic links indicated a large, interconnected web of affected healthcare facilities throughout New York City. Of the 51 clinical case-patients, 23 (45%) died within 90 days and isolates were resistant to fluconazole for 50 (98%). Of screening cultures performed for 572 persons (1,136 total cultures), results were C. auris positive for 61 (11%) persons. Environmental cultures were positive for samples from 15 of 20 facilities. Colonization was frequently identified during contact investigations; environmental contamination was also common.

KEYWORDS:

Candida auris; New York; United States; epidemiology; fungi; healthcare facilities; infection control; yeast

PMID:
30226155
PMCID:
PMC6154128
DOI:
10.3201/eid2410.180649
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for CDC-NCEZID Icon for PubMed Central
Loading ...
Support Center